Zoetis in the $350 million sale of its medicated feed additive and water soluble products portfolio to Philbro

On April 28, 2024, Zoetis, Inc. (NYSE: ZTS) and Phibro Animal Health (Nasdaq: PAHC) announced that they have entered into a definitive agreement by which Phibro will acquire Zoetis’ medicated feed additive and water soluble products portfolio and related assets for $350 million.  The acquired product portfolio consists of more than 37 product lines that are sold in approximately 80 countries.

Wachtell, Lipton, Rosen & Katz is serving as legal counsel to Zoetis.